3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
9
Rectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Squamous Cell Carcinoma of Head and Neck
6
Uterine Cervical Neoplasms
4
Small Cell Lung Carcinoma
4
Prostatic Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Glioblastoma
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Neoplasms
3
Nasopharyngeal Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma
2
Spinal Cord Neoplasms
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Cancer Patients
1
Radiation Injuries
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pelvic Neoplasms
1
Interventions
Leucovorin
3
Fluorouracil
3
Oxaliplatin
2
Folfox protocol
2
regorafenib
1
lenvatinib
1
donafenib
1
Surgical Procedures, Operative
1
Radiotherapy
1
Irinotecan
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cirrhosis, Familial, with Pulmonary Hypertension
×
Radiotherapy
×
Clear all
NCT06946849
2025-04-27
SED-RO-ICC
Shanghai Zhongshan Hospital
Phase 2
Not yet recruiting
76 enrolled